Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment

Dayangaç, Murat10.07.20192019-07-1010.07.20192019-07-102018Dayangaç, M. (2018). Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment. Joint International Congress of ILTS, ELITA and LICAGE içinde (213-213. ss.). Lisbon, Portugal, 23-26 May 2018.0041-13371534-6080https://hdl.handle.net/20.500.12511/3860Joint International Congress of ILTS, ELITA and LICAGE -- MAY 23-26, 2018 -- Lisbon, PORTUGALWOS: 000436897700436[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessReconversionCalcineurinImmunosuppressionRecipientsSafety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairmentConference Object102Supplement: 5213213Q1